Delivery Order SPE2DB22D1106-SPE2DB25FFDK5
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) under a firm fixed-price contract valued at $29,062.23. The delivery order, issued on September 12, 2025, carries an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive award. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a firm fixed-price delivery order by the Defense Logistics Agency valued at $4,196.73 for MULTAQ 400 MG tablets (60-count bottles). The award, executed on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive, non-set-aside contract delivery. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,181.52 for 60 tablets of MULTAQ 400 mg on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 MG tablets (60-count units) on June 16, 2025, with an ultimate completion date of June 17, 2025. This contract, valued at $9,756.31, utilizes firm fixed price terms and was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $4,824.44 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract action under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $17,446.83 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed-price contract with an ultimate completion date of August 19, 2025. This non-set-aside delivery order represents a single procurement action drawn from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $11,535.63 to AmerisourceBergen Drug Corp for 60 tablets of MULTAQ 400 mg on August 25, 2025, with a completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. MULTAQ (dronedarone) is an antiarrhythmic medication used in the treatment of atrial fibrillation and represents one...
- The Defense Logistics Agency awarded a delivery order valued at $1,019.92 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) under a firm fixed-price contract. The award was issued on September 17, 2025, with an ultimate completion date of September 18, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packages) under a firm fixed-price contract valued at $2,247.47. The award, issued on May 23, 2025, with an ultimate completion date of May 27, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performing location for this delivery order, which supplies pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,297.85 to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 MG tablets (60-count units). This firm fixed price contract, with an ultimate completion date of August 4, 2025, was competitively awarded without set-aside designation. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through...